InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.10
(
0.50%
)
US TECH 100
19,704.80
(
0.68%
)
Dow Jones
42,438.89
(
0.85%
)
Brent Oil
76.66
(
-0.89%
)
Bitcoin
61,021.04
(
-1.79%
)
Post# of 5204
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jerryp

Send PM Follow Ignore
Followers 30
Posts 15370
Boards Moderated 0
Alias Born 05/15/2002

jerryp

Re: Chimaera post# 1592

Monday, 09/21/2009 3:08:09 PM

Monday, September 21, 2009 3:08:09 PM

Post# of 5204
“With populations exceeding 33 million people in Canada and over 830 million people throughout Europe, the combined size of the pain market in these countries potentially exceeds that of the United States,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma. “As we move forward with the registration process in Canada and Europe, we also plan to continue seeking qualified licensing partners to market and distribute our pain reliever worldwide,”

I don't see it as likely. Maybe a possibility based on the above paragraph.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up